Did the COVID-19 Pandemic Just Turn TAVR Into an Outpatient Procedure?

Autor: Giri J; Department of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: jay.giri@pennmedicine.upenn.edu., Fiorilli PN; Department of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Cardiovascular Outcomes, Quality, and Evaluative Research, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Jazyk: angličtina
Zdroj: JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2022 Mar 28; Vol. 15 (6), pp. 599-602.
DOI: 10.1016/j.jcin.2022.02.004
Abstrakt: Competing Interests: Funding Support and Author Disclosures Dr Giri has served on advisory boards for Boston Scientific, AstraZeneca, and Inari Medical; and has received research support to the institution from Boston Scientific, St. Jude Medical, and Recor Medical. Dr Fiorilli has served on advisory boards for Edwards Lifesciences, Inc.
Databáze: MEDLINE